Dear IGR readers,
With less than four months before the start of the next World Glaucoma Congress, the Executive Office is full of activity. Final preparations for the program, logistical challenges and promotional efforts via multiple channels. For a sneak preview of the program, please click here.
The regular registration deadline for WGC-2019 is also fast approaching. Register today for the World Glaucoma Congress 2019 to save!
WGA stays committed to giving young ophthalmologists from Sub-Saharan Africa the opportunity to expand knowledge and skills in several subspecialties in ophthalmology. That is why we continue with the Fellowship program for 2019: attendance of WGC-2019 in Melbourne, Australia, and three months of training at an Australian institute: Royal Victorian Eye and Ear Hospital (Melbourne), Westmead Hospital (Sydney), Lion’s Eye Institute/Royal Perth (Perth), Flinders Hospital (Adelaide) or Sydney Eye Hospital (Sydney). More information on the 2019 Fellows can be found online at the WGA website.
In the previous issue of IGR we introduced a new column: ‘Get to know the WGA Executive Office’ to introduce you to members of our team. In this issue we provide you with a short bio of Shan Lin, the current Executive Vice President of the WGA.
We hope you enjoy reading this issue of the IGR. You can contact our WGA Executive Office (email@example.com) if you need any information or have questions on IGR or WGA-related matters.
Executive Vice President
Shan Lin, MD, is Research Director at the Glaucoma Center of San Francisco. He is former Director of the Glaucoma Service at the University of California, San Francisco, and the Zuckerberg San Francisco General Hospital. He is an author of over 220 peer-reviewed publications. His past leadership positions include Chair of the American Glaucoma Society’s Patient Care Committee, Chair of the Glaucoma Section of the Ophthalmic Technology Assessment Committee of the American Academy of Ophthalmology, Chair of the American Glaucoma Society’s Document Review Subcommittee, and President, Vice President and Program Chair of the Pacific Coast Oto-Ophthalmological Society (PCOOS). His past honors include the Heed Fellowship Award, the American Glaucoma Society and The Glaucoma Foundation’s Clinician-Scientist Awards, and the Mid-Career Award by the AGS. He has also been funded as a Principal Investigator by the National Institute of Health, including as a PI for the Ocular Hypertension Treatment Study (OHTS) study. He has been selected annually for ‘Best Doctors’ in the U.S. since 2009. He is currently on the editorial boards for the American Journal of Ophthalmology, Journal of Glaucoma, and AJO Case Reports.